| __timestamp | Bristol-Myers Squibb Company | Ultragenyx Pharmaceutical Inc. |
|---|---|---|
| Wednesday, January 1, 2014 | 4534000000 | 45967000 |
| Thursday, January 1, 2015 | 5920000000 | 114737000 |
| Friday, January 1, 2016 | 4940000000 | 183204000 |
| Sunday, January 1, 2017 | 6411000000 | 231644000 |
| Monday, January 1, 2018 | 6345000000 | 293998000 |
| Tuesday, January 1, 2019 | 6148000000 | 357355000 |
| Wednesday, January 1, 2020 | 11143000000 | 412084000 |
| Friday, January 1, 2021 | 10195000000 | 497153000 |
| Saturday, January 1, 2022 | 9509000000 | 705789000 |
| Sunday, January 1, 2023 | 9299000000 | 648449000 |
| Monday, January 1, 2024 | 11159000000 |
Data in motion
In the competitive world of pharmaceuticals, research and development (R&D) spending is a key indicator of a company's commitment to innovation. Over the past decade, Bristol-Myers Squibb Company and Ultragenyx Pharmaceutical Inc. have demonstrated contrasting approaches to R&D investment.
Bristol-Myers Squibb, a giant in the industry, has consistently invested heavily in R&D, with expenditures peaking in 2020 at nearly double their 2014 levels. This reflects a strategic focus on expanding their drug pipeline and maintaining a competitive edge. In contrast, Ultragenyx, a smaller player, has shown a steady increase in R&D spending, growing by over 1,300% from 2014 to 2023. This underscores their aggressive pursuit of niche markets and innovative therapies.
These trends highlight the diverse strategies within the pharmaceutical sector, where both scale and specialization play crucial roles in shaping the future of healthcare.
Comparing Innovation Spending: AstraZeneca PLC and Bristol-Myers Squibb Company
Bristol-Myers Squibb Company vs Takeda Pharmaceutical Company Limited: Strategic Focus on R&D Spending
Analyzing R&D Budgets: Bristol-Myers Squibb Company vs Incyte Corporation
R&D Insights: How Bristol-Myers Squibb Company and Verona Pharma plc Allocate Funds
Selling, General, and Administrative Costs: Bristol-Myers Squibb Company vs Ultragenyx Pharmaceutical Inc.
Bristol-Myers Squibb Company or Celldex Therapeutics, Inc.: Who Invests More in Innovation?
Comparing Innovation Spending: Zoetis Inc. and Ultragenyx Pharmaceutical Inc.
Comparing Innovation Spending: BeiGene, Ltd. and Ultragenyx Pharmaceutical Inc.
Sarepta Therapeutics, Inc. vs Ultragenyx Pharmaceutical Inc.: Strategic Focus on R&D Spending
Ultragenyx Pharmaceutical Inc. or Perrigo Company plc: Who Invests More in Innovation?
Research and Development Expenses Breakdown: Ultragenyx Pharmaceutical Inc. vs Amicus Therapeutics, Inc.
R&D Spending Showdown: Ultragenyx Pharmaceutical Inc. vs Taro Pharmaceutical Industries Ltd.